Stocktoria
IOVANCE BIOTHERAPEUTICS, INC. IOVA
IOVANCE BIOTHERAPEUTICS, INC. statistics & valuation
Market cap$1.9B
P / S7.2×
P / B2.7×
Net margin-148.4%
Return on equity-56.0%
FCF margin-127.6%
Return on capital-52.1%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | -153.1% | -240.9% | -38735.0% | — | — | — | — | — | — | — |
| Net margin | -148.4% | -226.8% | -37345.4% | — | — | — | — | — | — | — |
| FCF margin | -127.6% | -221.9% | -32305.3% | — | — | — | — | — | — | — |
| Return on assets | -42.8% | -40.9% | -56.9% | -59.6% | -44.0% | -33.8% | -57.3% | -25.7% | -59.3% | -30.8% |
| Return on equity | -56.0% | -52.4% | -76.0% | -79.2% | -55.1% | -39.5% | -66.1% | -26.5% | -63.3% | -31.7% |
| Current ratio | 3.20 | 3.74 | 2.79 | 5.24 | 5.69 | 11.59 | 8.10 | 33.02 | 15.56 | 34.12 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.